Navigation Links
Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results
Date:6/1/2011

HOBOKEN, N.J. and PHILADELPHIA, June 1, 2011 /PRNewswire/ -- Niiki Pharma announced today that it will present interim data from the ongoing Phase I clinical study for its lead product, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL. NKP-1339 is a novel transferrin targeted ruthenium based anti-cancer compound. The intracellular targets of NKP-1339 include GRP78, a key regulator of mis-folded protein processing. In preclinical studies, in vivo and in vitro activity has been demonstrated against multiple tumor types, including those resistant to other anti-cancer agents.

The NKP-1339 Phase I trial is a dose-ascending trial and determines the safety, tolerability, maximum tolerated dose (MTD) and pharmacokinetics of NKP-1339. A total of 16 patients with metastatic solid tumors resistant to standard therapies have been treated to date at six different dose levels. NKP-1339 treatment has been generally well tolerated, with the most common drug related side effects of grade 1-2 fever and mild flu-like symptoms. MTD has not been reached and NKP-1339 dose escalation continues. Signs of anti-tumor activity (stable disease greater than or equal to four months; tumor regression) have been observed. A patient with a neuroendocrine tumor (NET) of the small intestine has been on NKP-1339 therapy for over 13 months with a continuing minor response. The patient remains on NKP-1339 therapy. Another patient with the metastatic gastrinoma NET exhibited six months stable disease, and two patients with metastatic non-small cell lung cancer exhibited four months stable disease.

The NKP-1339 Phase I trial is being led by Dr. Daniel Von Hoff, Translational Genomics Institute, Arizona, and Dr. Howard Burris, Sarah Canon Research Institute, Tennessee. Reflecting on NKP-1339's novel mechanism of action, Dr. Von Hoff noted "Resistance to anti-cancer therapy remains a major challenge in treatment of patients with metastatic cancer. First-
'/>"/>

SOURCE Niiki Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
2. Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
3. Novel Device Shows Promise for Reducing HIV Among Men
4. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
5. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
6. International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
7. MonoSol Rx and KemPharm to Develop Novel PharmFilm® Product for ADHD
8. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
9. Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO
10. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
11. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... LA HABRA, Calif. , May 1, 2015 /PRNewswire-USNewswire/ ... to announce its 2015 health literacy award winners. The ... reward initiatives that make an impact on the practice ... that advance health literacy. IHA gives awards in three ... IHA also bestowed its Health Literacy Hero award. ...
(Date:5/1/2015)... 1, 2015 Semler Scientific, Inc. (Nasdaq: ... develops, manufactures and markets products that assist healthcare providers ... financial results for the first quarter ended March 31, ... 2015, Semler reported continued progress with year over year ... growth of 14%," said Doug Murphy-Chutorian , M.D., ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... 12, 2011 Reportlinker.com announces that a new ... Global Injectable Drug Delivery Market ... Report Description : ... * To define and measure the Injectable drug ...
... BOSTON, Oct. 12, 2011 PAREXEL International Corporation ... biopharmaceutical services provider, today announced that it has ... topics throughout the clinical development and commercialization lifecycle. ... are conversations with thought leaders from PAREXEL designed ...
Cached Medicine Technology:Global Injectable Drug Delivery Market (2010 - 2015) 2Global Injectable Drug Delivery Market (2010 - 2015) 3Global Injectable Drug Delivery Market (2010 - 2015) 4Global Injectable Drug Delivery Market (2010 - 2015) 5Global Injectable Drug Delivery Market (2010 - 2015) 6Global Injectable Drug Delivery Market (2010 - 2015) 7Global Injectable Drug Delivery Market (2010 - 2015) 8Global Injectable Drug Delivery Market (2010 - 2015) 9Global Injectable Drug Delivery Market (2010 - 2015) 10Global Injectable Drug Delivery Market (2010 - 2015) 11Global Injectable Drug Delivery Market (2010 - 2015) 12New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 2New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 3New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership 4
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company that ... the , May 5 - 7, 2015 Minnesota Safety ... the conference include its bestselling TaskMate sit stand solutions. ... 6100 TaskMate Executive. Features of the 6100 TaskMate Executive ... extended platform work surface and supply holders. Weighing 50 ...
(Date:5/2/2015)... Viejo, CA (PRWEB) May 02, 2015 ProText ... exclusively for use in Final Cut Pro X. ProText ... for use in Final Cut Pro X . ... single keyframe with Pixel Film Studios' ProText Kinetic 2. , ... Start by staggering two ProText Kinetic presets in the ...
(Date:5/2/2015)... May 02, 2015 Kare Visits LLC. launched ... for busy caregivers. Kare Visits offers relief for caregivers ... living facilities. According to the Caregiver Action Network, ... average of 20 hours a week caring for an elderly ... cost to hire a nurse, a caregiver is now empowered ...
(Date:5/1/2015)... Caicos Islands, BWI (PRWEB) May 02, 2015 ... website! It is http://www.thevenetiangracebay.com , and it ... it incorporates the stunning white and attractive turquoise hues ... study of Google, sixty seven percent of leisure travelers ... study showed that smartphones were used in the planning ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 TROY Healthcare ... Cerner Southeast Regional User Group (RUG) Conference in Atlanta, ... Southeast Regional User Group Conference provides a forum for ... who support all aspects of electronic medical record operations, ... Cerner software applications. , In addition to sponsoring the ...
Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3
... own natural alarm clocks which can be set subconsciously just ... conducted by scientists at the University of Lubeck in Germany ... them to anticipate the "stress" of getting up at different ... of the power of thought when it comes to controlling ...
... demanding - or who do shift work - could ... in the US showed that this heavy work was ... babies. ,Jobs which involved long periods of ... significantly linked with premature birth. Physically demanding work was ...
... is implanted permanently in the eye is safe and effective ... alternative for laser operations that correct nearsightedness by reshaping the ... Allan Vukich of the University of Wisconsin School of Medicine ... the results of a multicenter trial of patients who had ...
... serious morning sickness if they are pregnant with a girl, ... Norway between 1977 and 1985 showed there was a greater ... female child. ,Though there were more births of ... of mothers-to-be of girls being admitted to hospital suffering from ...
... and aspirin are equally effective in stroke prevention in the ... stopping platelets from clumping together, while warfarin acts on the ... help prevent blood clots in the brain that lead to ... more effective at preventing stroke, but causes more side effects ...
... self-contained artificial heart suffered bleeding in his brain in the ... latest setback caused swelling and made the patient, Robert Tools, ... said. // ,Robert Tools received the AbioCor mechanical ... the time, he was so ill he had been given ...
Cached Medicine News:Health News:The alarm clock in you 2
... Physician-office® is an internet ... (Solo practice, group practice ... complete their normal duties ... is a front office ...
... is a modular, Electronic Medical Record (EMR) system ... create a patient chart. ChartMaker is an ... M compliant patient notes, medical reports, letters, and ... ChartMaker is designed to be installed in a ...
... original EMR companies, with a wealth and ... With over a decade of clinical and ... design, corporate level training and support, enables ... medical practice to EMR. The unparalleled HL7 ...
... is dedicated to serving the needs ... ultimate tool to,run a better orthopaedic ... records software.,AcerMed's Orthopaedic-Edition EMR software has ... surgeons across the country resulting in ...
Medicine Products: